ACE inhibitor lisinopril in cardiac patients: results of evidence-based trials

ACE inhibitor lisinopril in cardiac patients: results of evidence-based trials

.

Saved in:

Bibliographic Details
Main Author:	S. Yu. Martsevich
Format:	Article
Language:	Russian
Published:	«FIRMA «SILICEA» LLC 2004-06-01
Series:	Российский кардиологический журнал
Online Access:	https://russjcardiol.elpub.ru/jour/article/view/2217
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

ACE INHIBITORS IN ARTERIAL HYPERTENSION TREATMENT: FOCUS ON LISINOPRIL
by: V. I. Podzolkov, et al.
Published: (2016-01-01)

LISINOPRIL USAGE IN CARDIOLOGIC PRACTICE: DATA OF EVIDENCE BASED MEDICINE
by: N. P. Kutishenko, et al.
Published: (2015-12-01)

ACE inhibitor lisinopril influence on left ventricular diastolic dysfunction and endothelial response in hypertensive patients with or without chronic heart failure
by: A. D. Kuimov, et al.
Published: (2004-06-01)

EVIDENCE-BASED CHOICE OF ACE INHIBITORS
by: G. E. Gendlin, et al.
Published: (2012-08-01)

EFFECTIVENESS AND SAFETY OF LISINOPRIL AND SIMVASTATIN COMBINATION – ELASTICA STUDY RESULTS
by: F. T. Ageev, et al.
Published: (2009-02-01)

ACE inhibitor zofenopril in treatment of myocardial infarction patients: review of SMILE Project trials
by: Yu. M. Lopatin
Published: (2006-04-01)

ACE inhibitors in patients with heart failure
by: O. P. Shevchenko, et al.
Published: (2008-10-01)

NEWS OF EVIDENCE-BASED MEDICINE: RESULTS OF THE IMPROVE-IT TRIAL AND THEIR IMPLICATIONS FOR CLINICAL PRACTICE
by: S. Yu. Martsevich
Published: (2015-09-01)

ACE inhibitors in patients with acute myocardial infarction
by: S. N. Tereshchenko, et al.
Published: (2005-08-01)

LISINOPRIL IMPLICATION IN THE CLINICAL PRACTICE
by: V. I. Podzolkov, et al.
Published: (2016-01-01)

ORGANOPROTECTIVE EFFECTS OF THE FIXED COMBINATION OF ANGIOTENSIN-CONVERTING ENZYME INHIBITOR LISINOPRIL AND DIURETIC HYDROCHLOROTHIAZIDE
by: E. A. Ryabikhin, et al.
Published: (2016-01-01)

NEPHROPROTECTIVE EFFECTS OF LISINOPRIL IN THE THERAPY OF HYPERTENSIVE PATIENTS WITH OBESITY
by: S. G. Shulkina, et al.
Published: (2018-05-01)

CHOICE OF LISINOPRIL FOR TREATMENT OF HYPERTENSION IN PATIENTS WITH CONCOMITANT DISEASES
by: N. A. Dzhaiani
Published: (2015-09-01)

CARDIOPROTECTIVE PROPERTIES OF LISINOPRIL: NEW POSSIBILITIES
by: V. I. Podzolkov, et al.
Published: (2018-07-01)

Lisinopril-Induced Burning Mouth Syndrome
by: Nithya Sridhar, et al.
Published: (2023-05-01)

Spirapril – a modern ACE inhibitor
by: V. M. Gorbunov
Published: (2005-06-01)

Pharmacology of modern ACE inhibitors: moexipril example
by: D. P. Khloponin, et al.
Published: (2007-10-01)

Lisinopril clinical effectiveness and safety in elderly patients with arterial hypertension
by: M. E. Statsenko, et al.
Published: (2007-02-01)

ACE Inhibitor-Induced Angioedema of the Bowel
by: Tabitha Campbell, et al.
Published: (2010-01-01)

SIGNIFICANCE OF BASELINE ACE ACTIVITY IN PATIENTS WITH METABOLIC SYNDROME WHEN ADMINISTRATION OF ACE INHIBITORS AND IMIDAZOLINE AGONISTS IS CONSIDERED
by: T. V. Aparina, et al.
Published: (2001-04-01)

MICROCIRCULATION IN CHRONIC HEART FAILURE PATIENTS TREATED WITH ACE INHIBITORS AND DIURETICS
by: Yu. I. Gurfinkel, et al.
Published: (2011-04-01)

ACE inhibitor trandolapril effectiveness in arterial hypertension
by: K. I. Tebloev, et al.
Published: (2008-04-01)

Cardiovascular disease and ACE inhibitors: focusing on enalapril
by: G. A. Baryshnikova
Published: (2007-12-01)

ACE inhibitors in the treatment of paroxysmal atrial fibrillation
by: B. A. Tatarsky
Published: (2005-06-01)

New potential of ACE inhibitors in clinical practice
by: D. V. Nebieridze, et al.
Published: (2010-10-01)

ACE INHIBITORS ARE RATIONAL PHARMACOTHERAPY OF ENDOTHELIAL DYSFUNCTION
by: M. P. Metrova, et al.
Published: (2016-01-01)

ACE inhibitors as a risk factor for hypoglycemia
by: Andrey Alexeevich Aleksandrov, et al.
Published: (2011-12-01)

ACE inhibitors and myocardial remodeling in patients with arterial hypertension and atrial fibrillation
by: O. N. Miller, et al.
Published: (2007-10-01)

RU28318, an Aldosterone Antagonist, in Combination with an ACE Inhibitor and Angiotensin Receptor Blocker Attenuates Cardiac Dysfunction in Diabetes
by: Ibrahim F. Benter, et al.
Published: (2013-01-01)

SOME ASPECTS OF THE LISINOPRIL USAGE IN ARTERIAL HYPERTENSION TREATMENT
by: N. A. Jaiani
Published: (2016-01-01)

Biopharmaceutical aspects of the development of transdermal forms of Lisinopril dihydrate
by: Shyteyeva Tatyana, et al.
Published: (2024-09-01)

ACE inhibitors: new perspectives in cardiovascular disease treatment
by: V. I. Makolkin
Published: (2005-10-01)

ACE inhibitor zofenopril effectiveness in arterial hypertension treatment
by: D. A. Napalkov, et al.
Published: (2008-12-01)

Adverse effects of ACE inhibitors and cardiovascular treatment tactics
by: V. A. Orlov, et al.
Published: (2005-06-01)

Lisinopril effects on platelet activity in patients with arterial hypertension and impaired glucose tolerance
by: I. N. Medvedev, et al.
Published: (2008-06-01)

Expert opinion on "Results of a pilot clinical trial of the safety and efficacy of an original glycoprotein IIb/IIIa receptor inhibitor drug in acute coronary syndrome"
by: S. Yu. Martsevich
Published: (2023-09-01)

ACE inhibitor effects of brachial artery structure and function in patients with arterial hypertension
by: L. V. Melnikova
Published: (2012-04-01)

Clinical efficacy and vasoprotection of ACE inhibitors and beta3blockers in patients with arterial hypertension
by: Zh. N. Namsaraev, et al.
Published: (2004-02-01)

Antihypertensive effects of ACE inhibitor perindopril: ASCOT-BLPA Study lessons
by: Yu. M. Lopatin
Published: (2006-06-01)

Clinical and cost-effectiveness of ACE inhibitors in patients with arterial hypertension and coronary heart disease
by: O. Yu. Korennova, et al.
Published: (2008-08-01)